Company intelligence / Profile preview
Cerberus Therapeutics
Cambridge/Boston, Massachusetts, United Statescerberustx.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Cerberus Therapeutics is an early-stage biotechnology company developing proprietary nanobody-based platforms for immune modulation. Their preclinical studies have shown that their VHH protein formulations can induce durable immune responses in models of autoimmune disorders and infectious diseases. The company’s technology has demonstrated lasting protection and therapeutic efficacy in halting progression to disease in animal models of multiple sclerosis and rheumatoid arthritis. Infectious disease programs are also at the preclinical stage, supported by strategic investment from the Bill & Melinda Gates Foundation[2].
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Nanobodies (VHHs derived from alpacas)Protein therapeuticsSmall molecule adducts (in combination with VHHs)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Bill & Melinda Gates Foundation (strategic investment for infectious disease program)[2]
Beyond the preview
Go deeper on Cerberus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cerberus Therapeutics.